[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD] (Q80156258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Steffen Heger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Götz-Erik Trott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael Meusers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Eberhard Schulz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Aribert Rothenberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Klaus Rettig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Rossella Medori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andreas Schreiner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Helmut Remschmidt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Vertreter der deutschen C-2000-045-Studiengruppe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

Zeitschrift fuer Kinder- und Jugendpsychiatrie und Psychotherapie

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

257-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1024%2F1422-4917.34.4.257

7 January 2021

10.1024/1422-4917.34.4.257

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16927568%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference